Immunic AG | WebDisclosure

Basculer en Français

10654	Companies
226660	Keywords
155120	Articles
120001	Press releases

Home
Companies
Immunic AG

PRESS RELEASE

published on 02/04/2026 at 12:30, 4 months 24 days ago

Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
Immunic to present additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, reinforcing potential in Progressive Multiple Sclerosis. Latest research findings to be shared at event

Immunic Vidofludimus Calcium Progressive Multiple Sclerosis Phase 2 CALLIPER Trial ACTRIMS Forum 2026
BRIEF

published on 01/07/2026 at 12:35, 5 months 21 days ago

Bilan d'Immunic 2025 : progrès et perspectives d'avenir

Vidofludimus Calcium Neuroprotection Essais Cliniques Sur La Sclérose En Plaques Réalisations Immunitaires Étapes Clés De La Biotechnologie
BRIEF

published on 01/07/2026 at 12:35, 5 months 21 days ago

Immunic Reviews 2025 Progress and Sets Sights on Future Goals

Vidofludimus Calcium Neuroprotection Multiple Sclerosis Trials Immunic Accomplishments Biotechnology Milestones
PRESS RELEASE

published on 01/07/2026 at 12:30, 5 months 21 days ago

Immunic Highlights 2025 Accomplishments and Upcoming Milestones
Immunic Inc. highlights its 2025 accomplishments & upcoming milestones including phase 3 trials for Vidofludimus Calcium in relapsing Multiple Sclerosis, positive data in Progressive MS, & potential for IMU-856 in weight management

Immunic Inc. Multiple Sclerosis Vidofludimus Calcium IMU-856 2025 Accomplishments
BRIEF

published on 11/26/2025 at 12:35, 7 months 2 days ago

Immunic to Join Evercore ISI Healthcare Conference in December

Biotechnology Immunic Investor Meetings Healthcare Conference Neurologic Diseases
BRIEF

published on 11/26/2025 at 12:35, 7 months 2 days ago

Immunic participera à la conférence Evercore ISI Healthcare en décembre

Biotechnologie Conférence Sur Les Soins De Santé Immunitaire Maladies Neurologiques Réunions Avec Les Investisseurs
PRESS RELEASE

published on 11/26/2025 at 12:30, 7 months 2 days ago

Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
Immunic to participate in the 8th Annual Evercore ISI Healthcare Conference in December. Dr. Daniel Vitt to speak at fireside chat on novel oral therapies for neurologic and gastrointestinal diseases

Gastrointestinal Diseases Immunic Neurologic Diseases Evercore ISI Healthcare Conference Daniel Vitt
BRIEF

published on 11/13/2025 at 12:35, 7 months 15 days ago

Immunic, Inc. Announces Third Quarter 2025 Financial Results and Updates

Financial Results Clinical Trials Immunic, Inc. Multiple Sclerosis Vidofludimus Calcium
BRIEF

published on 11/13/2025 at 12:35, 7 months 15 days ago

Immunic, Inc. annonce ses résultats financiers et ses mises à jour pour le troisième trimestre 2025

Résultats Financiers Essais Cliniques Sclérose En Plaques Vidofludimus Calcium Immunique, Inc.
PRESS RELEASE

published on 11/13/2025 at 12:30, 7 months 15 days ago

Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Immunic, Inc. reports Q3 2025 financial results and provides corporate update, highlighting vidofludimus calcium's therapeutic potential in multiple sclerosis. Phase 3 ENSURE trial data expected by 2026

Financial Results Immunic Inc. Vidofludimus Calcium Phase 3 Trials MS Therapy

Accesswire

Published on 06/29/2026 at 09:01, 2 hours 22 minutes ago

HM Exploration Discovers New Blind Massive Sulphide Lens at Lewis Pilley's Project
Published on 06/27/2026 at 16:50, 1 day 18 hours ago

Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 2 days 9 hours ago

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 2 days 11 hours ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 2 days 12 hours ago

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting

View all ACCESSWIRE

EQS Group

Published on 06/29/2026 at 11:03, 19 minutes ago

PNE successful in onshore wind energy tender on May 1, 2026
Published on 06/29/2026 at 11:01, 22 minutes ago

POS-Transaction in Own Shares
Published on 06/29/2026 at 11:00, 23 minutes ago

Original-Research: MustGrow Biologics Corp. (von GBC AG): BUY
Published on 06/29/2026 at 10:46, 37 minutes ago

Aroundtown SA: Release of a capital market information
Published on 06/29/2026 at 10:35, 48 minutes ago

Cherry SE Permanently Appoints Rogier Volmer as CEO, Committing to Continuity in Its Strategic Transformation

Les Echos

Published on 06/29/2026 at 10:56, 27 minutes ago

GUILLEMOT CORPORATION S.A. | Déclaration hebdomadaire des transactions sur actions propres du 22 au 26 juin 2026
Published on 06/29/2026 at 10:56, 27 minutes ago

GUILLEMOT CORPORATION S.A. | Weekly report share buyback from June 22 to June 26 2026
Published on 06/26/2026 at 17:45, 2 days 17 hours ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 2 days 17 hours ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 2 days 17 hours ago

Descriptif du programme de rachat d'actions

View all LES ECHOS COMFI WIRE